Mental Health Impacts of COVID-19 Vaccination

The roll-out of COVID-19 vaccines has not only reshaped the trajectory of the pandemic in terms of infection and mortality rates but has also exerted marked effects on mental health worldwide. For many individuals, receipt of a first or second dose has been accompanied by short-term reductions in anxiety and depressive symptoms, reflecting relief from fear of infection and a sense of regained control. Longitudinal evidence further suggests that vaccination can contribute to sustained improvements in psychological distress, particularly among those with elevated baseline symptoms. Conversely, large-scale cohort data from some regions indicate a small but measurable increase in self-reported depressive and anxiety disorders in the weeks following immunisation, underscoring the need to monitor vulnerable subpopulations. Gender and socioeconomic factors appear to mediate these responses, with some studies reporting greater benefit among women and those with prior psychological distress. At the population level, enhanced mental wellbeing post-vaccination has been linked to increased compliance with preventive behaviours, reduced healthcare anxiety and a modest rise in social engagement. Together, these findings highlight a multifaceted interplay between immunisation campaigns and psychological outcomes, emphasising the value of integrating mental health screening and supportive interventions into vaccine delivery programmes.

Research from Nature Portfolio

A nationwide longitudinal study in Japan employed repeated measures of the Kessler Psychological Distress Scale (K6) to assess changes in mental wellbeing before and after one or two vaccine doses. Participants who were vaccinated showed significantly lower distress scores at follow-up, with those exhibiting psychological distress at baseline demonstrating higher odds of improvement and those without baseline distress being less likely to deteriorate. This work underscores the potential for vaccination to foster resilience against pandemic-related mental health burdens.

Mental Health Impacts of COVID-19 Vaccination publication trend

The graph below shows the total number of articles in mental health impacts of covid-19 vaccination across all publications each year (not limited to Nature Index journals).

Technical terms

Psychological distress: A state characterised by symptoms of depression and anxiety affecting daily functioning.

Kessler Psychological Distress Scale (K6): A six-item questionnaire measuring non-specific psychological distress over the past 30 days.

Patient Health Questionnaire (PHQ-4): A brief four-item tool combining two questions on anxiety and two on depression to screen for mental distress.

Odds ratio (OR): A statistic that quantifies the strength of association between an exposure and an outcome.

Hazard ratio (HR): A measure of the relative rate at which an event occurs over time in one group compared with another.

References

1. Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea. Molecular Psychiatry (2024).
2. Short-term improvement of mental health after a COVID-19 vaccination. PLOS ONE (2023).
3. Mental health outcomes after SARS-CoV-2 vaccination in the United States: A national cross-sectional study. Journal of Affective Disorders (2021).
4. Possible contribution of COVID-19 vaccination to the subsequent mental well-being in Japan. Scientific Reports (2022).
5. COVID-19 vaccines and mental distress. PLOS ONE (2021).
6. Gender Differences of the Effect of Vaccination on Perceptions of COVID-19 and Mental Health in Japan. Vaccines (2023).
7. Changes in Mental Health and Preventive Behaviors before and after COVID-19 Vaccination: A Propensity Score Matching (PSM) Study. Vaccines (2021).